Ashton Thomas Securities LLC Takes Position in Agilent Technologies, Inc. $A

Ashton Thomas Securities LLC bought a new position in Agilent Technologies, Inc. (NYSE:AFree Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 14,018 shares of the medical research company’s stock, valued at approximately $1,799,000.

Several other institutional investors have also recently added to or reduced their stakes in A. Concurrent Investment Advisors LLC increased its holdings in shares of Agilent Technologies by 7.4% during the third quarter. Concurrent Investment Advisors LLC now owns 2,428 shares of the medical research company’s stock worth $312,000 after buying an additional 168 shares in the last quarter. TD Private Client Wealth LLC boosted its holdings in shares of Agilent Technologies by 5.6% in the 3rd quarter. TD Private Client Wealth LLC now owns 2,633 shares of the medical research company’s stock worth $338,000 after acquiring an additional 139 shares in the last quarter. Quent Capital LLC bought a new stake in Agilent Technologies during the 3rd quarter worth approximately $185,000. Tokio Marine Asset Management Co. Ltd. increased its holdings in Agilent Technologies by 6.1% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 9,819 shares of the medical research company’s stock valued at $1,260,000 after purchasing an additional 567 shares in the last quarter. Finally, First Horizon Corp acquired a new stake in Agilent Technologies during the 3rd quarter valued at $1,378,000.

Analyst Upgrades and Downgrades

Several analysts have recently commented on A shares. TD Cowen increased their target price on Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Wells Fargo & Company boosted their target price on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Finally, Robert W. Baird upped their target price on shares of Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 25th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $163.31.

Get Our Latest Analysis on Agilent Technologies

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the transaction, the vice president owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the transaction, the chief executive officer owned 33,448 shares of the company’s stock, valued at $5,017,200. The trade was a 27.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 16,401 shares of company stock worth $2,468,962 over the last 90 days.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $146.47 on Wednesday. The company has a market cap of $41.52 billion, a PE ratio of 32.05, a PEG ratio of 4.30 and a beta of 1.29. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27. The company’s 50-day moving average is $144.62 and its two-hundred day moving average is $133.04.

Agilent Technologies (NYSE:AGet Free Report) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter in the previous year, the company earned $1.46 EPS. Agilent Technologies’s revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be paid a $0.255 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.32%.

Agilent Technologies Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Recommended Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.